1. India Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Amrutanjan Health Care Limited

Amrutanjan Health Care Limited

AMRUTANJAN.BO
Amrutanjan Health Care LimitedIN flagBombay Stock Exchange
538.05
INR
-0.90
- -
15.56BMarket Cap
Amrutanjan Health Care Limited
AMRUTANJAN.BO
(Bombay Stock Exchange)

Recent

price

538.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
34.79
48.9
47.09
48.49
56.98
63.08
71.36
74.87
86.2
89.22
113.8
138.51
129.63
144.77
156.25
173.8
173.77
Revenue per Share
3.37
3.3
3.46
4.26
5.1
7.67
7.46
6.83
8.39
8.58
20.94
23
13.65
15.5
17.58
20.03
20.03
Basic EPS, GAAP
-1.51
-0.13
2.49
5.58
4.28
6.56
1.53
5.49
6.54
5.35
30.43
9.84
3.86
7.3
5.31
-6.58
- -
Free Cash Flow per Basic Share
1.75
1.74
1.74
1.75
1.95
3.76
1.4
1.92
1.95
3.15
1.98
4.27
4.94
4.61
4.59
4.56
- -
Dividend per Share
1
1
11.58
12.25
15.08
19.63
29.64
26.44
32.28
36.98
56.31
74.52
83.22
82.39
95.4
1
1
Book Value per Share
26.92
26.25
28.01
30.5
32.43
33.52
39.51
43.94
49.71
54.38
73.25
89.98
98.8
98.59
112.35
127.46
127.43
Tangible Book Value per Share
30
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
29
Basic Weighted Avg Shares
1,054
1,429
1,376
1,417
1,666
1,844
2,086
2,188
2,520
2,607
3,325
4,045
3,782
4,201
4,518
5,026
5,026
Sales/Revenue/Turnover
32.55
13.48
10.84
13.44
12.76
16.19
15.06
12.22
11.72
10.32
23.91
20.26
11.12
11.43
11.44
12.29
12.29
Operating Margin (%)
20
37
39
37
32
25
29
31
33
44
37
38
52
61
65
63
63
Depreciation Expense
102
96
101
124
149
224
218
200
245
251
612
672
398
450
508
579
579
Net Income, GAAP
35.03
38.19
34.62
35.79
38.28
35.14
34.16
39.16
28.92
27.2
25.29
25.82
25.74
27.4
26.47
25.64
25.64
Effective Tax Rate (%)
9.69
6.74
7.35
8.78
8.95
12.16
10.45
9.13
9.73
9.62
18.4
16.61
10.53
10.7
11.25
11.52
11.52
Profit Margin (%)
267
240
254
510
570
598
759
890
1,035
868
1,708
1,972
1,969
2,258
2,061
1,655
1,655
Working Capital
37
61
- -
- -
- -
- -
- -
- -
- -
11
7
3
4
14
17
14
14
LT Debt
1,014
965
823
892
950
982
1,157
1,287
1,457
1,594
2,156
2,651
2,908
2,885
3,266
3,702
3,702
Total Equity
21.96
11.47
9.76
12.57
13.48
20.66
20.95
14.47
16.68
13.92
33.37
25.95
11.39
12.18
12.51
13.11
13.11
Return on Invested Capital (%)
189.96
146.9
40.52
29.16
33.92
42.22
29.38
24.1
28.63
24.74
44.67
35.14
17.26
18.61
19.66
41.09
41.09
Return on Capital (%)
337.03
323.7
55.03
35.73
37.31
44.2
30.27
24.37
28.56
24.78
44.89
35.16
17.3
18.66
19.74
41.56
41.56
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
3
- -
4
LT Borrowings
- -
- -
- -
LT Finance Leases
16
- -
14
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
29
- -
29
Market Capitalization
20,639
19,323
14,313

Working Capital

FRC

•

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
2,922
- -
2,916
Cash, Cash Equivalents & STI
2,075
- -
1,787
Accounts Receivable, Net
383
- -
606
Inventories
355
- -
374
Total Current Liabilities
793
- -
1,262
Payables & Accruals
- -
- -
- -
ST Debt
3
- -
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.53%
11.69%
13.35%
Free Cash Flow
36.11%
-58.37%
-224.04%
Net Income, GAAP
16.68%
1.79%
13.93%
Sales/Revenue/Turnover
10.92%
9%
11.23%
Total Cash Common Dividend
12.33%
24.54%
-0.52%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
779
993
1,170
1,260
4,201
2025
837
1,099
1,228
1,354
4,518
2026
940
1,177
1,410
1,498
5,026

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2.4
2.36
6.05
- -
15.5
2025
1.6
4.08
6.66
5.25
17.58
2026
2.87
4.83
6.73
5.6
20.03

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.61
2025
- -
- -
- -
- -
4.59
2026
- -
- -
- -
- -
4.56
Similar Companies
Entourage Health Corp. (ETRGF)
Juva Life Inc. (JUVAF)
YourWay Cannabis Brands Inc. (HOB0.F)
Karo Pharma AB (publ) (KARO.ST)
HUTCHMED (China) Limited (HCM)
Auxly Cannabis Group Inc. (CBWTF)
Business
Amrutanjan Health Care Limited is an Indian company primarily engaged in the manufacturing and marketing of healthcare and wellness products. Its core products include analgesic and pain relief creams, balms, gels, and sprays marketed under the Amrutanjan brand; health tonics and dietary supplements; and wellness personal care products. The company offers a range of herbal and ayurvedic formulations targeting pain relief and general health improvement. Operating mainly in India, Amrutanjan Health Care Limited caters to retail consumers through pharmacies, supermarkets, and healthcare outlets. Founded in 1893, the company is headquartered in Chennai, Tamil Nadu. In recent years, Amrutanjan Health Care Limited has focused on revitalizing its product offerings and market presence by launching new variants of its flagship pain relief products, expanding its herbal and natural product portfolio, and enhancing its distribution networks. The company has established strategic partnerships to strengthen its supply chain and broaden its reach across both urban and rural markets. Additionally, it has embraced digital transformation initiatives for marketing and consumer engagement. There have been no major name changes or reorganizations reported within the last two years. Amrutanjan continues to maintain its legacy as a well-known brand in the over-the-counter healthcare and wellness segment in India. The company operates within the health care products industry, specifically targeting consumers seeking pain relief, wellness, and herbal health solutions. Amrutanjan primarily serves the Indian domestic market but also explores growth opportunities in neighboring regions. It remains one of India’s oldest and most recognized healthcare product companies with a heritage of over 130 years. This description presents a comprehensive overview of Amrutanjan Health Care Limited’s business activities, core products, recent developments, and market focus to meet the requirements for financial databases like Bloomberg, Reuters, or S&P Capital IQ.